HuGE Literature Finder
Records
1
-
4
Survival of bladder or renal cancer in patients with CHEK2 mutations. PloS one 2021 16 (9): e0257132. Z?owocka-Per?owska El?bieta, D?bniak Tadeusz, S?ojewski Marcin, van de Wetering Thierry, To?oczko-Grabarek Aleksandra, Cybulski Cezary, Scott Rodney J, Lubi?ski J |
Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Feb . Näslund-Koch Charlotte, Nordestgaard Børge G, Bojesen Stig |
Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Human molecular genetics 2007 Aug 16 (15): 1794-801. Brennan Paul, McKay James, Moore Lee, Zaridze David, Mukeria Anush, Szeszenia-Dabrowska Neonilia, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Bencko Vladimir, Foretova Lenka, Janout Vladimir, Chow Wong-Ho, Rothman Nathanial, Chabrier Amelie, Gaborieau Valerie, Odefrey Fabrice, Southey Melissa, Hashibe Mia, Hall Janet, Boffetta Paolo, Peto Julian, Peto Richard, Hung Rayjean |
CHEK2 is a multiorgan cancer susceptibility gene. American journal of human genetics 2004 Dec 75 (6): 1131-5. Cybulski C, Górski B, Huzarski T, Masoj? B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szyma?ska A, Szyma?ska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod S A, Lubi?ski |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: